Guanylate Cyclase-C Agonist, on Gastrointestinal Transit and Bowel Function in Patients with Constipation-Predominant Irritable Bowel Syndrome

نویسنده

  • Viola Andresen
چکیده

S 1) Andresen V, Haag F, Nolte F, Thiele HG. The RT6 Alloantigens: T cell specific surface molecules with NAD-Glycohydrolase activity. Proceedings. XI German Spring Conference of Immunology. March 1995 2) Haag F, Andresen V, Nolte F, Thiele HG. The rat T cell differentiation alloantigen RT6.2, but not RT6.1 auto-ADP-ribosylates itself. Proceedings. International Congress of Immunology, San Francisco, USA, July 1995 3) Poellinger A, Foerschler A, Andresen V, Klapp BF, Zimmer C, Moennikes H. Functional Magnetic Resonance Imaging of Visceral Stimulation at Intensities To Induce Aware Or Subconscious Perception. Eur J Neurorad 2003;45: A071 (S61) 4) Andresen V, Bach D, Poellinger A, C Tsrouya, A Foerschler, A Stroh, C Zimmer, BF Klapp, H Monnikes. Functional Brain Imaging of Visceral Stimulation at Intensities of Aware or Subconscious Perception in Patients with Irritable Bowel Syndrome. Proceedings. Annual Meeting American Psychosomatic Society, Orlando, March 2004 5) Andresen V, Bach D, Poellinger A, Tsrouya C, Foerschler A, Stroh A, Klapp BF, Zimmer C, Monnikes H. Viszerale Stimulation mit bewusster und unbewusster Wahrnehmung in Reizdarmpatienten und Probanden – eine fMRT-Sudie. Med Klinik 2004;99 (A): P108 (82) 6) Andresen V, Bach D, Poellinger A, Tsrouya C, Foerschler A, Stroh A, Schmidtmann M, Fach K, van der Voort IR, Wiedenmann B, Zimmer C, Klapp BF, Monnikes H. Cerebral response patterns to perception threshold adapted (PTA) rectal stimulation reveal alterations in the emotional processing of visceral sensory input in patients with irritable bowel syndrome (IBS) even at the level of subconscious stimuli. Gastroenterology 2004;126: A28 7) Andresen V, Tsrouya C, Bach D, Poellinger A, Foerschler A, Stroh A, Georgiewa P, Fach K, Schmidtmann M, van der Voort IR, Wiedenmann B, Zimmer C, Klapp BF, Monnikes H. Altered limbic response patterns to auditory stimuli in patients with irritable bowel syndrome (IBS) suggest generalized changes of emotional stimulus-processing. Gastroenterology 2004;126:A591 8) van der Voort IR, Schmidtmann M, Fach K, Werner C, Andresen V, Klapp BF, Wiedenmann B, Monnikes H. Altered Gastric Accommodation and Emptying Can Be Revealed in Dyspeptic Patients with Magnetic Resonance Imaging Gastroenterology 2004;126:A487 9) van der Voort IR, Abou-Rebye H, Fach K, Schmidtmann M, Andresen V, Werner C, Wiedenmann B, Klapp BF, Monnikes H. Tegaserod improves gastric emptying and alters myoelectrical activity in dyspeptic patients. Gastroenterology 2004;126:A643

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Linaclotide: A New Option for the Treatment of Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation in Adults

Chronic idiopathic constipation (CC) and irritable bowel syndrome with predominant constipation (IBS-C) are the 2 most common conditions among functional gastrointestinal disorders. Despite current multiple therapeutic options, treatment remains challenging and dissatisfactory to many patients. Linaclotide is a novel therapeutic agent, which is a guanylate cyclase receptor agonist that stimulat...

متن کامل

Review article: linaclotide for the management of irritable bowel syndrome with constipation

BACKGROUND Irritable bowel syndrome with constipation (IBS-C) represents a significant burden to patients and healthcare systems due to its prevalence and lack of successful symptomatic resolution with established treatment options. Linaclotide 290 μg has recently been approved by the European Medicines Agency (EMA) for moderate-to-severe IBS-C and by the US Food and Drug Administration for IBS...

متن کامل

Treatment Algorithm for Chronic Idiopathic Constipation and Constipation-Predominant Irritable Bowel Syndrome Derived from a Canadian National Survey and Needs Assessment on Choices of Therapeutic Agents

Background. Chronic idiopathic constipation (CIC) and constipation-predominant irritable bowel syndrome (IBS-C) are common functional lower gastrointestinal disorders that impair patients' quality of life. In a national survey, we aimed to evaluate (1) Canadian physician practice patterns in the utilization of therapeutic agents listed in the new ACG and AGA guidelines; (2) physicians satisfact...

متن کامل

Pharmacologic properties, metabolism, and disposition of linaclotide, a novel therapeutic peptide approved for the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation.

Linaclotide, a potent guanylate cyclase C agonist, is a therapeutic peptide approved in the United States for the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation. We present for the first time the metabolism, degradation, and disposition of linaclotide in animals and humans. We examined the metabolic stability of linaclotide in conditions that mimic t...

متن کامل

Linaclotide: evidence for its potential use in irritable bowel syndrome and chronic constipation

Both irritable bowel syndrome (IBS), characterized by chronic and recurrent abdominal pain and altered bowel habits, and functional constipation are highly prevalent gastrointestinal problems for which many patients seek medical advice. A diverse number of treatment approaches are currently recommended to treat persons with chronic constipation as well as patients with IBS in which constipation...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2011